Cyclophosphamide is a generic injectable solution and capsule prescribed to treat conditions such as certain cancers and nephrotic syndrome. The cost of cyclophosphamide, with and without insurance, ...
Efficacy of neoadjuvant immunotherapy in head and neck squamous carcinoma (HNSCC): A systematic review and meta-analysis. Utilizing the EORTC Item Library to develop a tailored patient-reported ...
Uppsala, Sweden - The risk of bladder cancer rises steadily with increasing cumulative dose of cyclophosphamide in patients with Wegener's granulomatosis (WG), although some of this risk is ...
Nexus Pharmaceuticals shared that on May 9, 2025, it won a patent litigation involving injectable cyclophosphamide, a drug that has been approved for certain kinds of cancer. Nexus had been pursuing a ...
Impact of Funding Source on Long-Term Outcomes in Prostate Cancer: Analysis of a Large Public Database From Sao Paulo, Brazil We retrospectively reviewed our institutional database to identify ...
More than one-quarter of the patients with AAV in the unmatched sample were initially treated with cyclophosphamide, making the findings clinically relevant. Patients with antineutrophil cytoplasmic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results